Medical research

FDA approves immunotherapy for dMMR endometrial cancer

The anti-programmed death receptor 1 (PD-1) monotherapy Jemperli (dostarlimab) received approval for treatment of mismatch repair-deficient (dMMR) recurrent or advanced endometrial cancer that has progressed after treatment ...

Diseases, Conditions, Syndromes

WHO study finds remdesivir didn't help COVID-19 patients

A large study led by the World Health Organization suggests that the antiviral drug remdesivir did not help hospitalized COVID-19 patients, in contrast to an earlier study that made the medicine a standard of care in the ...

Diseases, Conditions, Syndromes

Zerbaxa approved for hospital-acquired bacterial pneumonia

(HealthDay)—Zerbaxa (ceftolozane and tazobactam) has been approved for a new indication to treat hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia (HABP/VABP) in patients aged 18 years ...

Diseases, Conditions, Syndromes

Health officials 'cautiously optimistic' on Ebola response

The World Health Organization said Tuesday it is "cautiously optimistic" about efforts to curb the spread of Ebola in an urban area in Congo, although the lethal virus is still reported in at least two remote areas.

page 1 from 2